Since PA leads to changes in signaling pathways that may induce the activation of different kinases, we first examined the phosphorylation state of tau at four different phosphoepitopes (S199/S202, S214, S356, and S396), because the phosphorylation levels at these sites have been previously found to be increased in the brains of AD patients. Here, MAPT is linked to Alzheimer disease.